- Southwark CES Diabetes Guide for general practice diabetes management: helpful for pro-active care optimising management. Use in conjunction with LTC management guide
- Primary Care Diabetes Society has a Covid-19 resource centre (login required)
- Diabetes structured education still going strong whilst all face to face courses have had to be cancelled, on-line and telephone supported courses are now available across south east London via clinician or self-referral. There is plenty of capacity on all options so please continue to refer. Read more
- Cambridge Diabetes Education Programme (login required) – aimed at supporting staff providing first-line advice and support to people living with all types of diabetes during COVID-19
- The Lambeth Diabetes Intermediate Care Team delivered a webinar for Lambeth Borough colleagues in October on the challenges of managing obesity and type 2 diabetes and SGLT-2 inhibitors – preventing cardiovascular and renal disease. Click here to watch
NEW (8 Jan 2021) Clinical Risk stratification guidance
- COVID-19 Risk stratification pathways to support primary care and people with Diabetes- Diabetic Kidney Disease (DKD) Risk Stratification and High Risk Foot Disease Pro-active Management – covering letter
- COVID-19: Diabetes High Risk Foot Disease Pro-active Management Proforma
Sick Day Rules Information Sheets
- COVID-19: Diabetes High Risk Cohort Pro-active Management SEL Guidance
- How to undertake a remote diabetes review: Diabetes UK and Primary Care Diabetes Society
- Hypoglycaemia in adults in the community: Recognition, Management and Prevention
Diabetic Eye Screening
Update for on the SEL Diabetic Eye Screening Programme during covid pandemic (public information). Due to the pandemic, eye-screening had been halted.
SE London programme re-started routine screening clinics in July. A service update was published on 3 November.
PH England have issued guidance stating programmes can postpone screening for patients who attended after March 2019 and had a normal result for up to 1 year. This means that a large number of patients will have their next screening appointment up to 2 years from their last appointment. If patients are anxious about this they can contact us. This guidance is based on evidence that patients in this group have a very low risk of developing sight threatening disease.
The following patient groups will not be postponed and are being invited now:
· Pregnant patients due for a first or 28-week screen
· Patients in the digital surveillance pathway (e.g. those with early maculopathy)
· Patients whose last screening results was R1M0 (background diabetic retinopathy)
· New patients (newly diagnosed or newly moved into the area)
· Patients who we could not get clear images for, who need a slit lamp appointment to assess their eyes
· Patients who did not attend their last screening appointment